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Under the assumption of no unmeasured confounders, a large literature exists on methods that can
be used to estimating average treatment effects (ATE) from observational data and that spans regression
models, propensity score adjustments using stratification, weighting or regression and even the combination
of both as in doubly-robust estimators. However, comparison of these alternative methods is sparse
in the context of data generated via non-linear models where treatment effects are heterogeneous, such
as is in the case of healthcare cost data. In this paper, we compare the performance of alternative regression
and propensity score-based estimators in estimating average treatment effects on outcomes that are
generated via non-linear models. Using simulations, we find that in moderate size samples (n= 5000),
balancing on estimated propensity scores balances the covariate means across treatment arms but fails
to balance higher-order moments and covariances amongst covariates, raising concern about its use
in non-linear outcomes generating mechanisms.  We also find that besides inverse-probability weighting
(IPW) with propensity scores, no one estimator is consistent under all data generating mechanisms.
The IPW estimator is itself prone to inconsistency due to misspecification of the model for estimating
propensity scores. Even when it is consistent, the IPW estimator is usually extremely inefficient. Thus
care should be taken before naively applying any one estimator to estimate ATE in these data. We
develop a recommendation for an algorithm which may help applied researchers to arrive at the optimal
estimator. We illustrate the application of this algorithm and also the performance of alternative methods
in a cost dataset on breast cancer treatment.
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1. Introduction 
Average treatment effect (ATE) and other mean treatment effect parameters (such as 
the Effect on the Treated) are quintessential components of economic evaluation 
(Heckman and Robb, 1985; Heckman 1990, 1992; Manski and Garfinkel, 1992; Heckman 
and Smith, 1998; Dehejia, 2005). Researchers often rely on observational data to 
estimate these effects because they are relatively inexpensive to obtain and often provide 
population coverage. However assignment to treatment is typically not random in these 
data, but is instead based on several confounding factors that may also affect outcomes.  
The traditional way to adjust for these confounding variables is to do some variant of 
regression analysis, where the effect of the treatment is estimated after holding the levels 
of a variety of confounding covariates constant across the treatment groups (Altman, 
1998; Greenland et al, 1999). More recently, propensity score methods have been 
proposed and used as alternatives for estimating these effects.  In such methods, one 
estimates how various characteristics affect the probability of treatment receipt, creates a 
score based on this estimation and then compares observed outcomes between treated 
and untreated subjects conditional on this score (Rosenbaum and Rubin, 1983). The 
theory of propensity scores suggests that, conditional on this scalar propensity score, all 
of the selection bias generated by differences in observed covariate values between the 
treatment and control group can be removed.  
Proponents of propensity score methods have highlighted the robustness of these 
methods in comparison to regression methods when there are multiple covariates to 
adjust for, even though the later can be much more efficient when appropriately specified 
(Rosenbaum, 1987; Rubin and Thomas, 1996; Rosenbaum, 2002; Angrist and Hahn,   3
2004) while misspecified models for estimating the propensity scores can lead to biases in 
estimating treatment effects (Drake, 1993). However, these results on comparing 
propensity score methods to regression methods have been primarily established only in 
the context of linear data generating mechanisms. 
In this work, we will extend this comparison to outcomes data that are generated 
under a non-linear continuous data generating mechanism implying that treatment effects 
are heterogeneous across the population.
a We will use health care costs or expenditures 
as the prototype example of such an outcome measure, which also have non-normal 
characteristics: non-negative values and skewness on the right hand side. Many other 
outcomes in economics carry similar features – earnings (Dehejia and Wahba, 1999), 
income (Jalan and Ravallion, in press) and a variety of marketing outcomes such as sales 
(Rubin and Waterman, 2006), - and our results extend readily to these outcomes as well.  
There is a large literature since the 1960s that addresses skewness in outcome (e.g., 
cost or other) data and appropriate non-linear covariate adjustment methods that go with it 
(Box and Cox, 1964; McCullagh and Nelder, 1983; Mullahy 1998; Blough et al., 1999; 
Manning and Mullahy, 2001). For health care costs and expenditures,  it is typical to find a 
fraction of patients with expenditures much larger than the median patient that leads to 
large skewness and kurtosis on the right hand side of the cost distribution. The 
inapplicability of a linear model for this distribution, both in terms of bias and efficiency, 
has been consistently demonstrated.  On the other hand, even though the theory of 
                                                 
a Some existing work in econometrics do focus on such data while evaluating certain types of 
matching estimators where observations can be matched based on propensity scores using some 
pre-set callipers to define closeness of matches (see Imbens (2004) for a review). The consequent 
sample size for analysis relies on specific definitions of closeness of a match, since exact matches 
between treated and untreated subjects are rarely available. However, due to various 
generalizability issues that arise when a portion of the sample is not used in estimation, we do not 
deal with these methods in this paper. We discuss this issue further in our discussions section.   4
propensity score and its robustness issues has been extensively tested and supported in 
the context of a linear model and under normality assumptions, these issues remain 
largely unexplored in the context of data generated with non-linear mechanisms for 
continuous outcomes.  
Only recently, comparisons have been made between conditioning on propensity 
scores and regression-based covariate adjustments for binary responses and survival 
outcomes, which presumably follow non-linear data-generating processes (DGPs); the 
results indicating substantial differences in estimated effects between these two methods 
(Austin et al, 2007a; Austin et al, 2007b) . However, these papers highlight the fact that 
these differences are due to the definitions of treatment effects that each method 
employs. In non-linear regression, regression coefficient or some functions of the 
regression coefficients are interpreted as effects conditional on other covariates in the 
model. On the other hand, matching on the propensity score allows one to estimate 
effects that are marginal over the observed covariates.  Of course, one can construct 
similar treatment effects that are marginal over the observed covariates based on 
predictions from regression models, which would then be directly comparable to the 
results from propensity score methods. It is not clear, however, how alternative estimators 
would fare in direct comparison of these treatment effects marginal over observed 
confounders.  
  A fundamental concern about the application of propensity scores to such data is the 
need for propensity scores to not only balance the covariate means across treatment 
arms, but also address their full joint distribution. Imbalances in higher order moments and 
the covariances amongst covariates may lead to both bias and inefficiency in estimating 
treatment effects, even when the means are perfectly balanced.  To illustrate this   5
proposition, consider an exponential conditional mean model where E(Y|X) = exp(X1 + 
X2).  If X1, X2 are independent normal variables with mean 0 and variance 1, then EXE(Y|.) 
= exp(0 + 0.5*2) = 2.72 (Variance = 47.2).  Instead, if X1, X2 ~ N(0, 0.5), then EXE(Y|.) = 
1.65 (Variance = 4.67); if X1, X2 ~ N(0, 1) & Corr(X1, X2) = 0.1, EXE(Y|.) = 3 (Variance = 
72.4).  Thus, slight variation in the joint distribution of X could lead to substantial 
differences in both the expected outcomes and variances in a non-linear model.
b  
  Our objective in this paper is to explore the role of propensity scores and non-linear 
regression in the context of data generated via non-linear mechanisms. Specifically, we 
explore the advantages and disadvantages to using propensity scores compared to non-
linear covariate adjustment methods as well as combinations of both estimation strategies 
in estimating unbiased effects of alternative treatments or diseases on costs and other 
outcomes marginal to other covariates in the model. We expect that our results and 
discussions will provide necessary evidence and guidance for applied researchers: 
Q1.    Should we use propensity score methods for modeling non-linear data such as 
costs or should we rely on non-linear covariate adjustment methods? If we use 
propensity scores, which specific method is most appropriate for costs data? Should 
we use a combination of covariate adjustment and propensity score methods? 
Q2.    Are flexible covariate adjustment methods comparable to propensity scoring 
methods in terms of robustness to specification? How do the efficiencies from their 
estimations compare to each other? 
                                                 
b This concern extends to randomization too. Optimal sample sizes for a randomized experiment are often 
based on effect-sizes and their variances. However, randomization may require larger sample sizes for the 
joint distribution of the covariates to converge across treatment arms, a point that is underappreciated in the 
design of experiment literature.    6
Q3.    How sensitive are the results from propensity score methods to the 
specification of the model estimating the propensity scores?    
Throughout this paper, we will assume there are no hidden selection biases or other 
forms of endogeneity. It is well known that neither traditional regression-based 
adjustments nor propensity scores-based adjustment, nor any combinations thereof can 
address such hidden selection biases (Heckman and Navarro-Lozano, 2004).
c Therefore, 
we will make the conventional assumption of “selection of observables” (Heckman and 
Robb, 1985) or “treatment assignment strongly ignorable given observed covariates” 
(Rosenbaum and Rubin, 1983) that is employed at-large in the literature on regression 
and “matching”-based estimators, and assume that this selection bias can be addressed 
through observed covariates. 
  Our paper is organized as follows. In Section 2, we formally present our main 
parameter of interest, the average treatment effect (ATE),
d give an overview for the 
rationale for addressing selection biases in order to consistently estimate ATE, and the 
methods commonly employed in the context of analyzing costs data to address these 
selection biases. We discuss some earlier results on applying regression-based and 
propensity-based adjustments to analyzing costs of breast cancer patients. We revisit this 
empirical example in Section 6. In Section 3, we further motivate the readers in two ways: 
we show the assumptions required for one of the popular model for propensity–based 
adjustments to work; we then employ a simple simulation exercise which carries specific 
concerns about generic propensity-based adjustments for data generated via non-linear 
models. In Section 4, we describe the specific estimators we are going to study. In Section 
                                                 
c See also Wilde and Hollister (2007) for an illustration of this limitation.  
d Although we focus on ATE in this paper, our results generally extend to most other mean treatment effect 
parameters.   7
5, we present our full simulation designs, results and their implications for guidance to 
applied researchers on the questions raised above. Application of alternative estimators to 
the empirical example on the costs of breast cancer treatments is given in Section 6. 
Section 7 concludes with the discussion of our findings. 
 
2. Overview of addressing selection biases 
2.a. Primary parameter of interest and selection bias 
Selection bias occurs in observational data when there is an imbalance in the 
characteristics, which independently influence the outcome, Y, between those who 
receive treatment (T) and those who do not (S).
e  This type of bias is common in 
estimating mean treatment effect parameters such as the average treatment effect (ATE) 
because outcomes can be observed only in the state that corresponds to the chosen 
treatment.  To formally represent these ideas, we use the potential outcomes framework 
that is widely used in the statistics and economics literature (Fisher, 1935; Neyman, 1990; 
Roy 1951; Rubin 1974; Holland, 1986).
 The data generating process for the potential 












                  (   1   )  
where  (.) μ  represents the non-linear data generating mechanisms as a function of the 
observed covariates X = (X0, X1,.., Xk) that includes a vector of ones (X0). UT and US are 
                                                 
e We focus on the case of discrete treatment alternatives.  The case of marginal effects for changes 
in levels of continuous treatment variables follows a similar logic.   8
random errors, with E(Uj)  = 0, j = T, S. The primary interest is estimate to the average 
treatment effect (∆) parameter, which can be represented as the difference in potential 
outcome if patients are treated rather than not treated: 
  ∆=EX(YT-YS) =  (( ) ( ) ) XT T S S EX X μ βμβ −             (   2   )  
Note that, unlike in linear models, the treatment effect for each individual not only 
depends on the parameters β but also on the levels of X. This implies that the treatment 
effects are essentially heterogeneous in the population, a typical manifestation of non-
linear data generating processes. Therefore, the average treatment effect is obtained by 
averaging over the population distribution of X, as in EX(.). In most situations, each patient 
is only observed in state T or state S, but never both at any point in time.  Therefore, the 
observed outcome (Y) becomes (Fisher 1935; Cox, 1958; Quandt, 1972, 1988; Rubin, 
1978): 
   Y=DYT + (1-D)YS                  (   3   )  
where D is an indicator =1 if T is received and =0 if S is received. Consequently, the 
difference in the sample averages of the outcome variable between the treatment and 
control groups may fail to provide a consistent estimate for ATE because 
   (| 1 ) (| 0 ) =− = XX EE YD EE YD  
(| 1 ) (| 0 ) == −= XT XS EE Y D EE Y D  
(( ) | 1 ) (( ) | 0 ) XT XS EX DEX D μ βμ β == −=  
(( ) ) (( ) ) XT XS EX EX A T E μ βμ β ≠−=           (   4   )  
The last inequality follows because the distribution of the observed covariates may not be 
independent of the treatment group, i.e.,  (|) () ≠ EXD EX. The bias is generated because   9
the levels of observed factors (X) influencing outcomes are different for treated and the 
untreated group and is called overt selection bias (Rosenbaum, 1998). In this work, we 
focus on addressing overt selection bias.  
The bias generated because the levels of unobserved factors influencing outcomes 
are different for the treated and untreated groups is called the hidden selection bias. As 
we noted before, we assume away hidden selection bias and will not address the issue 
that arise when hidden bias in present.  
The primary method of addressing overt biases in observational studies is to adjust for 
observed information that affects outcomes. These methods can be jointly referred to as 
the methods of matching because they try to match or balance the levels of observed 
covariates between the treated and the untreated groups. Methods used in the context of 
health care costs data are discussed in detail below. 
 
2.b. Overview of non-linear model-based covariate adjustment  
for cost data 
Traditional linear regression usually fails to model well a skewed distribution. Even 
when the linear model is correct in the sense that response is linear with additive error, 
the least squares estimates could be unstable, due to skewness and kurtosis, and/or 
inefficient due to heteroscedasticity. Econometricians have historically relied on 
logarithmic or other Box-Cox transformations of Y followed by regression of the 
transformed Y on X using OLS, to overcome the skewness, with some hope that such a 
transformation will also reduce problems of heteroscedasticity and kurtosis (Box and Cox, 
1964). The main drawback of transforming Y is that the analysis does not result in a   10
model for () x μ in the original scale, a scale that in most applications is the scale of 
interest. In order to draw inferences about the mean () x μ or any functional thereof in the 
natural scale of Y, one has to implement a retransformation from the scale of estimation to 
the scale of interest.  This involves the distribution of the error terms in the scale of 
estimation (Duan, 1983; Manning, 1998). The retransformation is complicated in the 
presence of heteroscedasticity on the scale of estimation (Manning, 1998; Mullahy 1998).  
To avoid such problems of retransformation, biostatisticians and some economists 
have focused on the use of generalized linear models (GLM) with quasi-likelihood 
estimation (Wedderburn, 1974). In the GLM approach, a link function relates ( ) x μ to a 
linear specification
T x β of covariates. The retransformation problem is eliminated by 
transforming ( ) x μ instead of Y.  Moreover, GLMs allow for heteroscedasticity (in the raw-
scale) through a variance structure relating (| ) = Var YX xto the mean, correct 
specification of which results in efficient estimators and may correspond to an underlying 
distribution of the outcome measure (Crowder, 1987). The use of GLM models is 
increasingly becoming popular in modeling health care costs data (Bao, 2002; Killian et al, 
2002; Bullano et al, 2005; Ershler et al., 2005; Hallinen et al., 2006).
 
However, there is often no theoretical guidance as to what should be the 
appropriate link function or the variance function for the data at hand.  One approach to 
this problem is to employ a series of diagnostic tests for candidate link and variance 
function models; examples include the Pregibon link test (Pregibon 1980), the Hosmer-
Lemeshow test (Hosmer and Lemeshow, 1995).  However, in many cases, even if these 
tests detect problems, they do not provide any guidance on how to fix those problems.  
Some tests, such as the modified Park test (Manning and Mullahy, 2001) can be   11
employed conditional on the appropriate specification of the link function, which may be a 
strong assumption.     
Basu and Rathouz (2005), propose an alternative semi-parametric method to estimate 
the mean model () μ x and the variance structure for Y given X, concentrating on the case 
where Y is a positive random variable.  Following McCullagh and Nelder (1989) and 
Blough et al. (1998), they use a mean model that contains an additional parameter 
governing the link function using the Box-Cox-type link function, and also use parametric 
models for the variance as a function of () μ x .  However, unlike previous versions, Basu 
and Rathouz’s method estimates all the additional model parameters simultaneously 
along with the regression coefficients using extended estimating equations that maximize 
a quasi-likelihood function. Hence it is named as the Extended Estimating Equations 
(EEE) estimator. The flexible estimation method they propose has three primary 
advantages: First, it helps to identify an appropriate link function and jointly suggests an 
underlying model for the error distribution for a specific application; second, the proposed 
method itself is a robust estimator when no specific distribution for the outcome measure 
can be identified. That is, their approach is semi-parametric in that, while they employ 
parametric models for the mean and variance of(|) YXthey do not employ further 
distributional assumptions or full likelihood estimation methods. Finally, their method helps 
to decouple the scale of estimation for the mean model, determined by the link function, 
from the scale of interest for the scientifically relevant effects as is typical in the health 
economics literature. That is, regardless of what link function is used, treatment effects 
such as the ATE, on any scale can be obtained.  
   12
 
2.c. Overview of conditioning, stratifying or weighting with 
propensity scores  
Propensity score (PS), e(X), is the conditional probability of exposure to treatments 
given the covariates, i.e., e(X) = Pr(D = 1|X). Rosenbaum and Rubin (1983) show that 
conditional on this propensity score all of the overt bias generated due to differences in 
observed covariates values between the treatment and control group can be removed. 
That is treated and untreated (controls) subjects selected to have the same value of e(X) 
will have the same distribution of X, thereby accounting for the overt biases. Conditioning 
on a scalar propensity score instead of multiple covariates also helps to reduce the 
dimensionality of a matching problem (Lu and Rosenbaum, 2004). Typically, the 
propensity score e(X) is estimated from a model, such as a logistic regression model, 
log[ ( )/{1 ( )}] θ −= eX eX X , and then one uses various estimators that effectively matches 
treated and untreated observations based on the estimated propensity score ˆ() eX or on 
ˆ θ X .   
There are several methods by which PS can be utilized in order to achieve balance of 
observed covariates.  These methods include conditioning, stratifying or weighting 
outcomes based on the estimated PS.
f The most commonly used methods of PS 
matching involves an OLS regression of outcomes on PS, treatment indicator and their 
interaction, adjusting for quintiles of PS, and inverse PS weighting of the outcomes.  
                                                 
f As discussed in the Introduction section, we do not evaluate calliper-based matching 
estimators. We discuss this issue further in the Discussion section.   13
Among these, Lunceford and Davidian (2004) have recently shown that the quintile 
approach can produce inconsistent estimates of the ATE. 
The use of PS for adjusting for covariate imbalances has gained popularity over the 
past few years in the context of modelling costs and cost-effectiveness analysis. Coyte et 
al. (2000) estimate costs associated with alternative discharge strategies following joint 
replacement surgery using propensity scores. Mojtabai and Zivin (2003) use PS methods 
for estimating the cost-effectiveness of four treatment modalities for substance disorders. 
Both of these works used adjusting for propensity quintiles. Similarly, Polsky et al. (2003) 
conduct economic evaluation of breast cancer treatments using propensity scores. More 
recently Mitra et al. (2005, 2006) have proposed a propensity score approach to 
estimating the cost–effectiveness of medical therapies from observational data. In their 
method, they use the OLS regression with PS approach but did not include an interaction 
with the treatment indicator. Their results show that estimates of net health benefits 
obtained via propensity score matching are similar to those obtained via covariate 
adjustment using OLS, albeit the former is slightly more efficient.  Although the authors 
recommend the use of propensity score methods, their result raises several concerns in 
the context of skewed outcomes data. First, PS methods are found to be only slightly 
more efficient than the OLS regression, which itself is an extremely inefficient estimator 
with skewed outcomes data. This suggests that an appropriate non-linear model for such 
data can produce large efficiency gains. Second, the mean estimates are very similar 
between propensity scores and OLS, where OLS often produces biased estimates with 
skewed data, raising further questions regarding the consistency of propensity score 
methods in modelling data that are most likely generated using non-linear mechanisms. 
This issue is further motivated in Section 3.   14
2.d. Overview of combination approaches – propensity scores + 
covariate adjustments:   
Using simulations, Rubin founds that if the model used for model-based covariate 
adjustment is correct, then model-based adjustments may be more efficient than 
propensity score matching (Rubin, 1973). On the contrary, if the model is substantially 
incorrect model based adjustments may not only fail to remove overt biases, they may 
even increase the bias, whereas propensity score matching methods are fairly consistent 
in reducing overt biases. Similarly, methods based on weighing the data with estimated 
propensity score may be inconsistent if the model used to estimate the propensity scores 
is misspecified. Rubin concludes that the combined use of propensity score matching 
along with model-based covariate adjustment is the superior strategy to implement in 
practice, being both robust and efficient. Unfortunately, this approach is almost never 
followed in practice. 
Moreover, almost all studies that explored the performance of propensity score 
methods combined with covariate adjustment have done so by using the traditional linear 
models and sometimes employed with the normality assumption (Rubin and Thomas, 
1992, 1996; Lunceford and Davidian, 2004). Extensions of these results to the non-linear 
framework are only now beginning to emerge.  
  Recently, a series of papers have developed estimators that are “termed” doubly 
robust (DR) and rely on the combinations of propensity matching and covariate 
adjustments (Robins et al., 1995; Scharfstein et al., 1999; Bang and Robins, 2005). This 
work tries to resolve the controversy on the use of propensity matching (or weighting) 
models and covariate adjustment models by developing estimators that are consistent   15
for () μ x  whenever at least one of the two models (covariate adjustment or propensity 
score) is correct. This class of estimators is referred to as doubly robust as because it can 
protect against misspecification of either the covariate adjustment model or the propensity 
score model.  It cannot protect against simultaneous misspecification of both. As Bang 
and Robins (2005) write  
“In our opinion, a DR estimator has the following advantage that argues for its 
routine use: if either the [y-model] or the [e-model] is nearly correct, then the bias 
of a DR estimator of µ will be small. Thus, the DR estimator . . . gives the analyst 
two chances to get nearly correct inferences about the mean of Y.” 
However, newer work (Kang and Schefer, 2007) on comparing alternative strategies of 
addressing missing data reveals that although DR methods perform better than simple 
inverse-probability weighting, they are sensitive to misspecification of the propensity 
model when some estimated propensities are small and none of the DR methods the 
authors employ improve upon the performance of simple regression-based prediction of 
the missing values. To date, these methods have not been tried on costs data. 
 
3. Motivating the need to compare the performance 
of propensity-based adjustments with non-linear 
models 
  We present two ideas here which will help motivate why one should carefully study the 
performance of alternative propensity score methods on data generated via a non-linear   16
model. First, we lay out the assumptions required for a popular estimator, which uses 
propensity scores, to work. Next, using a simulation exercise, we illustrate specific 
concerns that arise with most propensity-based adjustments when applied to data 
generated via non-linear models. 
One of the popular models used for adjustments with propensity scores is a linear 
OLS model where the observed outcome is regressed on an indicator of treatment, the 
estimated propensity score and the interaction between them. This estimator is given in 
detail under Method P2 in the next section. The model implies that the treatment effect 
varies linearly with the estimate propensity score. However, this assumption can often be 
violated where data is generated via non-linear models.   
  The theory of propensity score says that under the assumption of strongly ignorable 
treatment assignment (which formally implies that YT, YS  D | X, where  denotes 
statistical independence),  
          YT, YS  D | e(X)            (   5   )  
so that treatment exposure is unrelated to the counterfactuals for individuals sharing the 




|( ) (( ) ) ( ) |( ) jX e X j j eX E X eX μμ β = , j = S, T,          (   6   )  
representing the expected potential outcome conditional on the propensity score. 
Therefore, due to the assumption of strongly ignorable treatment assignment as noted in 
(5), the average treatment effect can be identified and written as: 
∆=EX(YT-YS) =  { }
**
() ( ( )) ( ( )) eX T S Ee X e X μμ −           (   7   )    17
Each of the components of ATE, 
*(( ) ) j eX μ , can be written as a first-order Taylor series 
expansion about e(X) = e μ where (( ) ) e EeX μ = : 
*(( ) ) j eX μ  = 
** ()( () ) () ( | () | ) je e j e e eX o eX μ μμ μ μ μ
′ +− ⋅ + −      (   8   )  
where 
* () j e μ μ
′  is the first derivative of 
*() j e μ μ  with respect to e(X) and evaluated at e(X) 
= e μ . Therefore, 
E(YT-YS|e(X)) = 
{ } { } { }
** * * * * () () () ( | () | ) Te Se e S T T S e eX o eX μ μ μ μ μμμ μμ μ
′′ ′′ ⎡⎤ −+ ⋅ − + ⋅ − +− ⎣⎦  
                          (   9   )  
Equation (9) shows that the ATE arising out of a non-linear data generating mechanism 
can be approximated by a simple model where the treatment effect is allowed to vary 
linearly over e(X) (which corresponds to Method P2 described in Section 4).
g  This is an 
approximation which hold true at  () e eX μ = , where  {( |( ) | ) } e Eo eX μ − =0. The treatment 
effect at that point will be{}
** () () Te Se μ μμ μ − . However, the extent to which such a 
simplification may be successful to capture the true ATE would really depend on how the 
non-linearity of potential outcomes in X translates to linearity of potential outcomes in 
e(X). For example, a second order Taylor series expansion of (7) would lead to: 
E(YT-YS) = {}
** () () Te Se μ μμ μ −  +  { }
** {( ) } TS Var e X μ μ
′′′ ′ ⋅−      (   1 0   )  
                                                 
g Note that unlike the model used by Indurkhya et al.  (2006), this suggest that one should include an 
interaction of the treatment indicator with the propensity scores in the OLS regression of outcomes.   18
where 
* () je μ μ
′′  is the second derivative of 
*() je μ μ  with respect to e(X) and evaluated at 
e(X) = e μ , and the second term in (10) represents the bias that would arise from a 
simplification as in (9).  
Therefore, it is evident that the problems that arise due to misspecification of function 
form in regular regression-based estimators would continue to persist in regression 
models with propensity scores.  
  Besides the limitations for the specific model above, any method of propensity score 
fundamentally depends on the assumption of strongly ignorable treatment assignment as 
in (5). This also implies that the conditional distribution of the observed covariates X given 
e(X) is the same for the treated (D=1) and the control (D=0) subjects (i.e. X  D | e(X)).   
  Unfortunately, what has received relatively less attention in the literature is that 
whether the rate of convergence for the equality of the conditional distribution of X 
between treatment groups may be slower for the conditional joint distribution compared to 
the marginal distribution of X. Additionally, the rate of convergence for the equality of the 
conditional higher order moments of X may be slower that the equality in the conditional 
means of X.
h This aspect is of particular importance in the context of data generated via 
non-linear mechanism where the expected value of the outcome depends on the joint 
distribution of X.  As such, whether conditioning on estimated PS can achieve equality of 
the entire joint distribution of X in moderate sample sizes (~2000 – 10000) typical of most 
health economic applications remains to be an open question. Note that this is not a 
concern in regression models, since in regression models, once the parameters are 
                                                 
h This is evident from that fact that most balancing tests devised to look at the equality of 
conditional distributions have focused on the mean of the X’s. See Imai et al (2006) for a review 
and criticism of these tests.   19
estimated, the treatment effect is calculated by directly averaging predictions over the 
empirical joint distribution of X in the sample. 
To illustrate this, we design a simulation to study whether conditioning on PS results in 
equality of not only the mean of the covariates across the two treatment groups, but also 
achieves equality on the higher order moments and the joint distribution of these 
covariates across treatment groups.  We simulate the joint distribution of three 
covariates 123 {, ,} = X XXX , where X1 is a binary covariate. We generated 1,000 replicate 
samples of 5,000 each for the vector 
**
123 {,,} XX X X =  following  
**
11 1 ~ (0,1), ( 0.5) XU n i f o r m X X => 
*
21 ~0 . 6 2* 2* ( 0 , 1 ) ; + XX U n i f o r m and 
*
31 ~0.42* 2* (0,1). XX U n i f o r m +  
The correlations between them are given by  ** 23 12 13 0.25, 0.18, 0.06 ρ ρρ = == , where 
(, ) ′ jj Corr X X   ρ ′ = jj . These correlations are in line with the typical correlations we observe 
between covariates in a cost regression.
i Using these covariates, we then define 
treatment choice (D = 0,1) using a logit index model where ~( ) D Bernoulli p , and 
[ ] ( )
22
123 1 2 2 3 ( ) 0 ln(1.5) ln(0.5) ln(0.5) ln(1.5) ln(2.0) ln(1.75) ⎡⎤ ⎡⎤ =+ ⋅+ ⋅ + ⋅ + ⋅ ⋅ + ⋅ + ⋅ ⎣⎦ ⎣⎦ logit pX X X X X XX
                     ( 11 ) 
                                                 
i For example, in our empirical example, we found that the correlation between indicator nonwhite 
and covariate representing percentage under poverty level was about 0.25, between Charlson’s 
comorbidity  index scores and indicator high payment for services was about 0.18 and a myriad 
number of correlations that exist in the range of 0.05 to 0.15.   20
The coefficients in (11) are fixed arbitrarily so that about 70% of the population receive 
treatment.
j  
  We estimate the PS, e(X), in each replicate sample based on a logistic regression of D 
using the same specification as in (11). We estimate the mean of X and standard 
deviation of X for each treatment group when they share the same propensity scores 
rounded to two decimal places. Similarly, we estimate the correlation between any two X’s 
for each treatment group when they share the same propensity scores rounded to one 
decimal place. Results are averaged over 1000 replicate samples. Figure 1(a) reports the 
densities of PS by treatment group. It shows that the densities exist over the same regions 
for both the treatment group. Figures (b), (c) and (d) report connected plots of the means, 
standard deviations and correlations among the X’s by treatment status conditional on the 
estimated PS. As expected, conditional on the estimated PS, we find that the X’s have 
almost identical means in both treatment groups. However, they do not have identical 
standard deviation or correlations, with the biggest discrepancies arising at the upper end 
of the estimated propensity scores. This implies that in many practical instances, 
propensity scores may fail to remove imbalances in the joint distribution of covariates 
across treatment groups. To what extent this limitation would affect estimation of 
treatment effects would depend on the degree of non-linearity in the data-generating 
model of the particular study population.  
Our initial simulation exercise and the derivations above motivate our interest in a more 
formal study of these issues. 
                                                 
j This is also in line with our empirical example where 75% of the breast cancer patients get 
mastectomy. 
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4. Alternative estimators for ATE 
We focus on three covariate adjustment methods, three methods of adjustment by 
propensity score alone, and three additional methods where covariate adjustment are 
simultaneously used with propensity score matching. We use the word ‘estimator’ 
interchangeably with ‘method’ to refer to these alternatives. These methods are given in 
details below.  The three methods of covariate adjustments are: 
i)  Method C1 / OLS - Ordinary Least Squares (OLS) Regression: Here, the mean 
function () μ x is assumed to be a linear model with additive error and the regression 
model is written as 
   η ε =+ Y   and  01 η ββ β =+⋅ +
T
X DX           (   1 2   )  
 where  ε is an i.i.d. error term, D is the treatment indicator variable and X 
represents other covariates. This is also the generic linear predictor that we will 
use for all remaining estimators unless otherwise stated. 
ii)  Method C2 / log-GLM - Generalized Linear Model (GLM) with Log Link (McCullagh 
and Nelder, 1989): Here the mean function () x μ is related to the linear 
predictorη with a log link. And a gamma variance structure is assumed for 
modeling heteroscedasticity, 
  log( ( )) μ η = X and Var(Y|X) 
2 (( ) ) X φμ =⋅          (   1 3   )    
iii)   Method C3 / EEE – EEE estimator (Basu and Rathouz, 2005): Here the mean 
function () x μ is related to the linear predictor with a Box-Cox link,    22
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where the link parameter is estimated directly from the data. Additionally, similar to 
the link function, a family 
2
12 1 (;,)
θ μ θθ θ μ = ii h of variance functions indexed by (θ1, θ2) 
is used, where the variance parameters are also directly estimated form the data. 
All parameters in the model, given by the parameter vector γ = (β
T, λ, θ1, θ2)
T, are 
estimated using an additional set of estimating equations following a Fisher-
Scoring algorithm yielding estimator ˆ γ . The predicted mean in this model is 
obtained by: 
1
ˆ ˆˆ ˆ() ( 1 )
T xx λ μβ λ =⋅ + . Further details on this estimator can be found 
elsewhere (Basu and Rathouz, 2005).  
The methods of propensity score (PS) matching that we will use are: 
i)  Method P1 / PS-quintile – Stratifying by quintiles of PS: This is the most commonly 
used methods of propensity scores (Rosenbaum and Rubin , 1983; Rubin, 1997; 
Little and Rubin, 2000). Here the empirical distribution of propensity scores across 
the entire sample (including treated and untreated patients) are divided into 
quintiles. Indicator variables for the first four quintiles are then used as covariates 
along with the treatment indicator and the interactions between them in an OLS 
regression, 
η ε ′ =+ Y  and  ( )
4
01 2 3 1 ηαα α α
= ′ =+⋅ + ⋅+ ⋅ ⋅ ∑ jj jQ j Q j DI D I       (   1 5   )  
  where 
j Q I is the indicator for the j
th quintile. 
ii)  Method P2 / OLS-PS- OLS Regression with PS: Here the outcome variable is 
regressed on the treatment indicator, the estimated propensity score and the   23
interaction of the treatment indicator with the propensity score using ordinary least-
squares, 
    η ε ′ =+ Y  and  01 2 3 ˆˆ () () ηαα α α ′ =+⋅ +⋅ +⋅ ⋅ De X D e X       (   1 6   )  
iii)  Method P3 / IPW - Inverse Weighting with PS: Following Rosenbaum (1998) and 
Hirano, Imbens and Ridder (2003), the difference in weighted average of the 
outcomes between treatment and untreated group gives a consistent estimate of 
the ATE, where the weights are proportional to the inverse of the estimated 
propensity scores. Hirano, Imbens and Ridder claim that this approach would also 
give an efficient estimate of ATE, although they provide evidence of this claim only 
in the context of linear models. We follow their proposed method and estimate 
ATE as  
   
11
11 1 1
1( 1 ) ˆ
ˆˆ ˆ ˆ () () 1 () 1 ()
NN N N
ii i i i i
ii i i ii i i
DD Y D D Y
eX eX eX eX
−−
== = =
⎛⎞ ⎛ ⎞ ⋅ −− ⋅
Δ= ⋅ − ⋅ ⎜⎟ ⎜ ⎟ −− ⎝⎠ ⎝ ⎠ ∑∑ ∑ ∑        ( 17 ) 
    Note that this estimator is similar to the Horvitz-Thompson estimator (1952).
  
iv) Method P4 / DR.  Doubly Robust (DR) Alternatives. Next, we study three more 
methods that use PS, where simultaneous covariate adjustments are also done. 
The underlying rationale for these estimators follows the works of Robins and 
colleagues in developing a doubly robust (DR) estimator (Robins et al., 1995; 
Scharfstein et al., 1999; Bang and Robins, 2005). The basic formulation of this 
doubly robust estimator is as follows:   24
() () Xg μ η′′ = where 
11
01 1 2 ˆˆ () ( 1 ) ( 1 () )
T
X DX D e X D e X ηβ β β γ γ
− − = + ⋅+ +⋅⋅ + ⋅− ⋅− and 
(|) () Var Y X h X = .               ( 18 ) 
Compared to the covariate adjustment model in Model C1-C3, the linear predictor 
in equation (18) contains two additional covariates that are the inverses of a 
subject’s estimated propensity score. Following this generic formulation, we study 
three different doubly robust estimators mirroring the covariate adjustment 
methods in Model C1-C3:  
a) Method P4a / OLS-DR - DR estimator with OLS Regression - Here g(.) = 1 and 
2 () hX σ = .  
     b) Method P4b / log-GLM-DR - DR estimator with GLM Gamma model with log 
link - Here the model is same as in (13) but now η η′′ = . 
c) Method P4c / EEE-DR - DR estimator with EEE regression - Here the model is 
same as in (14) but now η η′′ = .  
Note that for any method, the estimate for the incremental effect is obtained using the 
method of recycled predictions (Oaxaca, 1973, Manning et al, 1987). In this method, 
ˆ(, () ) μ ii x ex  is predicted using estimated model parameters from covariate adjustment or 
PS/DR methods. We average the predictions ˆ ˆ(, 1 , () ) μ = ii i x de x across all individuals i (i =1, 
2,..,N). Here,  i x and i d are the values of  X andD for the i
th observation. Note that we have set 
1 = i d  for all i. We then assign the value of 0 to D for all the individuals as if they are not 
treated and average the predictions ˆ ˆ(, 0 , () ) μ = ii i x de x across these individuals. Here the hat   25
()
∧ on ˆ μ indicates that the regression parameters have been estimated. The difference in the 
mean ( ˆ μ ) between the two scenarios gives us the estimated ATE, ˆ Δ :  
     ˆ Δ  =
1
1
ˆˆ { ˆ (, 1 , () ) ˆ (, 0 , () ) }
N
ii i ii i
i
Nx d e x x d e x μμ
−
=
=−= ∑ .           (   1 9   )  
 
 
5. Simulation designs and results  
5.a. Designs 
Our simulation study compare the performance of three covariate adjustment 
methods, C1-C3, to the alternative propensity score methods, P1 – P4(a-c), under a 
variety of non-linear data generating processes (DGP).   Depending on the underlying 
data generating process, one or more of the covariate adjustment methods represents a 
misspecified estimator. Similarly, for the propensity score matching methods P1 – P4, the 
estimator specified to estimate the propensity score could either be misspecified or 
correctly specified. Additionally, for the doubly robust methods P4a – P4c, both, none or 
either one of the covariate adjustment method or the propensity estimator could be 
misspecified.  
We use the same design points for the data on covariates and treatment receipt 
described in Section 3 above. We do not use the exact specification that generated the 
treatment choice data for estimating the propensity scores because in an actual analysis 
the analyst would never know the true functional form generating choices. Instead, using 
logistic regression, we estimate a saturated model that includes all second-order   26
polynomials of X and the one-way interactions among them. Although this is an over-
specified model given our data, it should not produce systematic biases in the prediction 
of propensity scores. We also estimate an unsaturated model, where only the main effects 
of X are used, and represent the misspecified propensity score estimator. Therefore, in all, 
we study fifteen estimators corresponding to methods C1-C3, and two versions of P1-P3 
and P4a-P4c based on varying the model estimating the propensity scores between the 
unsaturated and the saturated models. 
All of the four outcome data-generating processes (DGP) we consider belong to the 
gamma distribution (shape = 2.0), which corresponds to a skewed-right bell-hsaped 
distribution.  They differ in their degrees of non-linearity between their mean and X’s 
through different link functions and non-linear functional forms.  The four mean functions 
are given as: 
D1. 
2.5
12 3 ( | , ) (100 800 250 250 50 ) EY DX D X X X =+ ⋅ + ⋅ + ⋅ + ⋅  
D2:  ()
4 (|,) 2 . 50 . 2 2 () EY DX D pX
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⎛⎞ ⋅ ⎛⎞ +⋅ + ⋅ + ⎜⎟ ⎜⎟ ⎝⎠ ⎜⎟ =
⎜⎟ ⋅⋅ −⋅ ⋅ + + − ⎜⎟ + ⎝⎠
 
D4.  ()
1 ( | , ) 0.4 0.266 0.4 ( ) 25 ( ) EY DX D pX D pX
− =+ ⋅ − ⋅ + ⋅ ⋅  
Here, p(X) is given as the expit(.) of the linear predictor in (11). Y is scaled to have a 
mean of 1. The coefficients are chosen so that the absolute standardized ATE, where 
absolute ATE is divided by the standard deviation of Y, is 1 under each DGP. Except for 
the combination of the EEE (Method C3) and DGP D1, all other regression estimators are   27
essentially misspecified for any given DGPs. Of special interest are the mean functions of 
DGPs D2 and D4 as they are non-linear functions of p(X) themselves and therefore we 
expect the OLS-PS model to fail based the theoretical reason stated in equation (10). 
We generate 1,000 replicate samples of 5,000 each under each data generating 
mechanism.  For each replicate data set and under each of nine different estimators (k = 
1,2,..15), we estimate the average treatment effect  ˆ Δk computed using (19), the predicted 
means  ˆ () k x μ =
1 ˆ () ik
i
nx μ
− ⋅∑ , the root mean square error (RMSE)  = 
()
2 1 ˆ () ik ik
i
ny x μ
− ⋅− ∑ and the mean absolute error (MAE) =
1 ˆ |( ) | ik ik
i
ny x μ
− ⋅− ∑  . We 
report the % mean bias (and 95% CI) in estimating Δ  under each methods that is given 
by  ˆ (( ) ) 1 0 0 / k True True E Δ− Δ ⋅ Δ . (95% CI calculated using the standard deviation of  ˆ Δk  across 
replicates). We also report the relative mean absolute error (RMAE) and the relative root 
mean square error (RRMSE) for each method relative to the inverse-propensity weighting 




Table 1 reports the descriptive statistics for our DGPs and the associated ATE. Figure 
2 illustrates the density of outcome Y from each DGP, where Y is scaled to have mean 1 
in each case.  All DGPS shows substantial skewness and kurtosis on the right hand side 
of the distribution, typical of most costs datasets.    28
Figures 3(a) and (b) illustrate the %Mean Bias (and 95% CI) along with the RMAE and 
RRMSE for all methods under the DGPs D1 and D2 respectively. Under DGP D1, as 
expected, we find that the EEE method (C3) is consistent while the log-GLM (C2) and 
OLS (C1) methods are not. Methods P2 and P3 produce biased estimates of ATE when 
the propensity scores are estimated using the misspecified model. Method P1 is less 
prone to the misspecified propensity model, most likely due to its reliance on quintiles and 
not the actual level of the estimated propensity scores.   When the saturated model is 
used to estimate propensity scores, we find that all of the propensity score-based 
methods, the PS-Quintile approach (P1), the OLS-PS (P2 ) and the IPW (P3) approaches 
produce consistent estimate of ATE. The EEE-DR (P4c) produce consistent estimate of 
ATE but have about 2.5 times higher standard errors for ATE compared to C3. The OLS-
DR (P4b) and log-GLM-DR (P4c) produce consistent estimates only when prediction of 
propensity from the saturated model is used, upholding the doubly robust feature of the 
estimator, although they are even more inefficient than EEE-DR.  They produce biased 
results with the misspecified propensity score model, as they become “doubly 
misspecified” under this data-generating mechanism. The optimal estimator under DGP 
D1 is the EEE (C3). 
Under DGP D2, EEE (C3) is again consistent while the log-GLM (C2) and OLS (C1) 
are not. However, in this case, the propensity score methods P1 and P2 are inconsistent 
even when propensity scores are generated via the saturated model. Method P3 (IPW) 
produces consistent estimates of ATE, however it is extremely inefficient. Compared to 
P3, method C3 attains a 32% reduction in both RMSE and RMAE. The OLS-DR estimator 
is also consistent, although at an expense of efficiency. Other DR methods have difficulty 
converging under this DGP. The optimal estimator under DGP D1 is also the EEE (C3).   29
Figures 4(a) and (b) illustrates the %Mean Bias (and 95% CI) along with the RMAE 
and RRMSE for all method under the DGPs D3 and D4 respectively. Under DGP D3, we 
find all the three regression based estimators produce biased estimates of ATE. All of the 
propensity score methods, P1, P2 and P3, produce consistent estimates of ATE, with P2 
being the most efficient. All the DR estimators produce consistent estimates of ATE, again 
upholding the doubly robust feature of the estimators.  This is especially true for the log-
GLM DR estimator (P4b), which is consistent for estimating ATE only when propensity 
scores are estimated via the saturated model. The optimal estimator under DGP D3 is the 
OLS-PS (P2) when the propensity score estimates came from the saturated model.  
Under DGP D4, regression-based estimators, OLS (C1), log- GLM (C2), EEE and the 
propensity-based estimators, P1 and P2, are all biased for estimating ATE. The inverse-
probability weighted estimator, P3, is consistent only when propensity scores are 
estimated via the saturated model, but, nevertheless, is extremely inefficient. EEE-DR 
(model P4c) is the only doubly-robust estimator that produces consistent estimates of 
ATE. In fact, it also produces 41% reduction in the RMSE and MAE compared to P3, and 
becomes the optimal estimator under this DGP. 
 
5.c. Summary of simulation results and an algorithm to choose 
best estimator 
Our simulations reveal several key features about the use of propensity scores to 
estimating treatment effects in data generated via non-linear DGPs. The fact that 
traditional methods (such as OLS and even log-link GLM) may not always capture the 
underlying data generating mechanism is well known. The EEE regression method   30
provides quite a bit of flexibility to this end by estimating a link parameter from the data 
that can guide the functional form based suited for the data at hand. However, even the 
EEE is not the answer to all sorts of non-linear data generating mechanism (as we see in 
the case of DGP D3). Propensity scores provide an alternative approach to overcome 
some of the limitations of functional form inherent in regression methods, although these 
approaches are also sensitive to specification of the propensity score estimator and are 
generally quite inefficient. Nevertheless, instead of viewing the propensity score methods 
as alternatives to regression methods, we have argued that they can serve as effective 
complements.  
To summarize the main results from our simulations in the context of estimating 
the ATE from data with non-linear DGPs, we find that: 
1.  Using inverse probability weight (IPW) is the most robust PS method, - it is 
always consistent but is often a severely inefficient estimator. 
2.  Doubly robust estimators are sensitive to both misspecifications of the 
propensity score estimators and also of the regression methods. 
Misspecification in one of them is often compensated by correctly specifying the 
other method, although this double robustness comes at an expense of 
efficiency. Efficiency of DR estimators lie somewhere in between the regression 
methods and the IPW estimator. 
3.  Stratifying by quintiles of PS  or OLS regression with PS can provide a robust 
and a much more efficient alternative to the IPW estimator for a variety of 
nonlinear DGPs. However, like the EEE method, they are not guaranteed to 
provide unbiased estimates for all types of nonlinear DGPs. The OLS regression 
with PS is usually more efficient that the quintile approach.   31
Based on these observations, we recommend the following algorithm for choosing the 
optimal estimator. This algorithm is illustrated in Figure 5. First, one should pay attention 
to the estimation of propensity scores. Very much like any regression analysis, a variety of 
goodness of fit should be used to check for systematic biases in the prediction of 
propensity scores. Once the analyst has a good model for propensity score, the first step 
is to estimate ATE and its standard errors (SE) using an appropriate regression method 
and also the IPW approach. Besides doing tradition checks of model fit for the regression, 
the analyst should check to see whether the mean estimate of ATE from the IPW method 
ˆ () IPW Δ falls within the 95% CI for the regression-based estimate for ATE. If so, then the 
analyst can stop and select the regression method as the optimal estimator. If not, then 
the analyst should run the OLS-PS and check whether the 95% CI it estimates for ATE 
contains  ˆ
IPW Δ . If so, then the OLS-PS is the optimal estimator. If not, then the analyst 
should select the regression model most suited to the data and apply a doubly robust 
estimator. Following the same rule as before, if the 95% CI that the DR estimator 
estimates for ATE contains ˆ
IPW Δ  the DR becomes the optimal estimator. If not, IPW 
becomes the best available estimator for estimating ATE.  
We now illustrate the application of this algorithm is selecting the optimal estimator for 
estimating the ATE between two treatment options among breast cancer patients.  
 
6. Empirical example 
Breast cancer is the second leading cause of cancer death in US Women.  With 
advances of screening and early detection, most cases of breast cancer are diagnosed in   32
early stages, when survival is excellent (Rias et al, 2000). However, costs associated with 
treatments of breast cancer patients are quite substantial. Local therapies for early-stage 
breast cancer include breast-conserving surgery with radiation (BCSRT) and mastectomy. 
Large clinical trials that studied the efficacy of these treatments find that BCSRT and 
mastectomy are equivalent in terms of long-term survival (NIH Consensus Conference , 
1991).  These results have increased the relevance of comparing costs across alternative 
treatments for early-stage breast cancer. 
Several cost studies have compared surgical treatments for early-stage breast cancer. 
These studies indicate that BCSRT may be more expensive than mastectomy, but 
evidence is not conclusive (Norum et al, 1997; Desch et al., 1999; Given et al., 2001; 
Barlow et al, 2001; Warren et al, 2002). Most have used ordinary least squares regression 
to model costs (one exception is Given et al. (2001), who use log-OLS regression, 
although without dealing with issues of retransformation). Polsky et al. Report an 
economic evaluation of breast cancer treatments using propensity scores,
 but find their 5-
year incremental cost estimate between BCSRT and mastectomy ($14,054, 95% CI, 
$9,791 - $18,317) is similar to that estimated via OLS regression ($13,775, 95% CI, 
$9,853- $17,697).  
 
6.a. Data 
Our data came from the Center for Medicare and Medicaid Services national claims 
database of a 5% random sample of all Medicare beneficiaries. The data were collected 
as part of the Outcomes and Preferences in Older Women Nationwide Survey (OPTIONS) 
project (Hadley et al., 1992), and were used by other researchers (Hadley et al, 2003;   33
Polsky et al, 2003). The dataset was constructed in four steps: 1) Medicare claims for 
persons with a breast cancer diagnosis or relevant surgery procedure codes for calendar 
years 1992 to 1994 were obtained. 2) Additional exclusions were applied so that the 
sample was limited to women for whom breast-conserving surgery with radiation (BCSRT) 
and mastectomy (MST) would be considered equivalent from the clinical point of view 
(Hadley et al, 2003; Polsky et al, 2003). Cases for which breast cancer was not the 
primary diagnosis were deleted. 3) Surgeons identified in the dataset were surveyed to 
verify study eligibility of the patients based on the presence of primary stage I and II 
invasive disease and the absence of the preceding exclusion criteria (as in (2)). 4) 
Additional exclusions were applied to exclude patients who were in a Medicare health 
maintenance organization in the month of the survey because their cost data were not 
available in the claims file. Finally, patients who had breast-conservation surgery but did 
not receive radiation are excluded. The data, although over 10 years old at this point, 
provides a unique opportunity to analyze a large national sample of Medicare 
beneficiaries with confirmed local stage of breast cancer. Moreover, we chose this dataset 
for comparability to results published in the literature based on this dataset (Hadley et al, 
1992; Hadley et al, 2003; Polsky et al, 2003).  
All 5-year Medicare payments from inpatient, outpatient, and physician Part-B 
claims are used to estimate direct medical costs, including costs related to breast cancer 
treatment and all other medial costs covered by Medicare. The total costs are calculated 
using an annual 3% discount rate. The final sample consisted of 2,517 patients of which 
1,813 patients had mastectomies and the remaining had BCSRT. The distribution of 
patient characteristics by treatment type is published elsewhere (Polsky et al, 2003).  The 
covariates that we adjust for are variables that are both measurable and theoretically   34
predictive of costs. In addition to the treatment group, we included age at the time of 
surgery, cancer stage, Charlson co-morbidity index and race. Because claims do not 
contain socioeconomic data, we use percentage college graduates, median household 
income, and percentage below poverty level by 5-digit zip-code level of the women’s 
residence.  Additionally, we adjust for county-level data on health system characteristics, 
such as hospital admissions, number of nursing homes and an indicator for urban area. 
We assume that there are no unobserved confounders. 
 The primary goal of the analysis is to estimate the average treatment effect of BCSRT 
over MST on total costs.  For the sake of completeness we apply all the estimators that 
we evaluated in our simulations. However, we give special emphasis on the use of the 
algorithm we recommended above in arriving at the optimal estimator. In order to estimate 
propensity scores, we start with a saturated logistic regression model that include all 
quadratic terms and two-way interactions besides the main-effects and then follow a 
stepwise approach with backward selection to arrive at a model that show reasonably 
good fit to the treatment choices.  
 
6.b. Results 
The final logistic regression estimator for estimating propensity scores passes all the 
goodness of fit test conducted based on raw-scale residuals (Pearson correlation test, rho 
= 0.002, p-value = 0.94; Pregibon’s Link Test, z = -0.20, p-value = 0.85; and Hosmer-
Lemeshow test, F =0.93, p-value = 0.51). Figure 6 (a) shows the distribution of estimated 
propensity score to select BCSRT for the two treatment categories. There are a few 
instances where exact matches in propensity scores are not obtained across both   35
treatment categories. However, we do not exclude observation based on this imbalance. 
We discuss this issue more broadly in the discussion section.  
We also look at the overall levels of balance in the covariate means. We run a 
seemingly unrelated regression where each covariate is regressed on the BCSRT 
indicator and the estimated propensity score. We find that the p-value on the coefficient of 
the BCSRT indicator is close 0.98 for every covariate that indicates excellent overall 
balance in the covariate means across treatment groups once adjusted for propensity 
scores. The joint test of the coefficients across all covariates is also highly insignificant (p-
value =0.99). However, a closer look at the distribution of covariates across estimate 
propensity score reveals greater discrepancies.  Figure 6(b) shows the level of match 
attained between treatment groups after conditioning on the estimated propensity scores 
for 3 statistics: (1) the mean and (2) the standard deviation of one of the covariates, the 
Charlson’s score, and (3) the correlation between Charlson’s score and median 
household income. We find substantial discrepancies in all the three statistics even in 
regions where the estimated propensity scores have substantial probability density mass. 
Table 2 reports the estimated incremental effects and their standard errors from 
alternative estimators. Figures 6 (a) & (b) illustrates the goodness of fit for the 
regressions, OLS-based PS and the DR estimators in terms of raw-scale residuals over 
their corresponding deciles of linear predictors. Both OLS and the log-link GLM methods 
show curvature in the raw-scale residuals over the deciles of their linear predictors. In fact 
both of them fail the Pregibon’s Link test (OLS: z = -3.01, p-value =0.002; GLM: z = -6.01, 
p-value < 0.001). The EEE on the other hand show no systematic biases and passes all 
goodness of fit test.  The systematic problems in prediction persist in the OLS-DR and the 
GLM-DR methods as shown in Figure 7(b) and is evident through the Pregibon’s Link   36
tests (OLS-DR: z = -5.75, p-value =<0.001; GLM: z = -3.01, p-value = 0.003). The OLS-
PS estimator, on the other hand show no such systematic biases but appear to be less 
efficient than either the EEE or the EEE-DR estimators.  
  These features translate to the average treatment effects shown in Table 2. The 
OLS and the log-link GLM regression estimators produce ATEs that are significantly 
different from the EEE estimate at the 10% and 5% levels respectively. The quintile-based 
PS and the log-GLM-DR estimators produce bigger discrepancies than the OLS 
regression estimate, but each is quite inefficient for its estimate to be significantly different 
that the EEE estimate. The OLS_PS, the IPW and the OLS_DR and the EEE-DR 
estimators produce consistent estimates of ATE but are inefficient.  
Therefore following our algorithm in Figure 5, we see that the EEE estimator’s 
estimate of ATE is $9,983 with 95% CI of ($7,337, $12,629). Since this interval contains 
the ATE estimate of $10,994 from the IPW estimator, we conclude that the EEE is the 
best estimator for this data.  
 
7. Discussions 
  In this paper, we have compared the performance of various regression-based , 
propensity score-based, and doubly robust estimators (which uses both approaches) in 
estimating average treatment effects on outcomes that are generated via non-linear data 
generating processes.  Using simulations, we find that besides inverse-probability 
weighting (IPW) using propensity scores no one estimator is consistent under all data 
generating mechanisms. The IPW estimator is prone to inconsistency due to 
misspecification of the model for estimating propensity scores. Even when it is consistent,   37
the IPW estimator is usually extremely inefficient. Thus care should be taken before 
naively applying any one estimator to estimate ATE in these data.   
  We have developed an algorithm that applied researchers can employ to arrive at the 
optimal estimator. We illustrate the application of this estimator and also the performance 
of alternative methods in a cost dataset on breast cancer treatment. 
  One limitation of our analyses is that we have not explored other potential methods of 
propensity score matching, such as the nearest available matching or the Mahalanobis 
metric matching. The drawback in using these methods is that they may result in the 
reduction of sample size by failing to find appropriate matches to the treatment receivers 
and not using all the available controls. Consequently, comparison to the covariate 
adjustment methods, which uses the full sample, in terms of efficiency becomes difficult. 
Furthermore, we assume in our work that empirical distribution of covariates in both the 
treatment and control groups are drawn from the same population distribution of 
covariates and, therefore, all the available controls can be effectively used in the 
analyses.  
  There is a philosophical debate that one can engage about the practice of excluding 
observations when exact or near exact matches in propensity scores are not found in 
either treatment group (Lechner, 2001). The dilemma is quite stark. Proponents of this 
approach have argued rightfully that if the distributions of some confounders do not 
overlap substantially in the treated and untreated groups, the regression relationship is 
determined primarily by treated subjects in one region of the X-space and by untreated 
subjects in another. Thus the estimates of average treatment effects using direct modeling 
are essentially based on extrapolation.  Although, it would be nice to have an index or 
statistics that summarizes the degree of extrapolation, what we would argue is that in   38
many cases such extrapolation is necessary, and any attempt to present results without 
extrapolation is potentially misleading. The tenet of this argument rests on the scientific 
merit of the treatment effect we are trying to estimate. If the policy decision we are to 
make with the analysis and the estimate of ATE (often the case in cost analysis) is to say 
something about the change in costs if the entire population gets one treatment versus 
another, then such extrapolation in regression based model is necessary to capture the 
whole population of interest, even if we have to make informed guesses for some factions 
of the population. That is our best estimate of ATE given the data at hand.
k  
  It is understandable that caution must be exercised in interpreting ATE estimates, if 
the imbalance is quite large. Clearly, the more prudent conclusion may be that the ATE 
cannot be identified with the data at hand.
l However, it does not imply that one should 
report a treatment effect estimate based on only the matched cases and controls. Such an 
approach, that produces a local average treatment effect, could translate to treacherous 
public policy decisions as it is not clear, in the context of heterogeneous treatment effects 
that we study here, which part of the population this estimate applies to. It also has the 
danger to being interpreted as an ATE, which it is certainly not.  
  We hope that our results, discussions and the recommended algorithm for selecting 
optimal estimator will provide necessary evidence and guidance for applied researchers, 
who plan to use these methods on observational studies for nonlinear outcomes such as 
health care costs. 
                                                 
k Ofcourse, there is a distinction between estimating regression coefficients and estimating ATE that is a 
function of both regression coefficients and the distribution of X  in the population. One might argue that a 
prudent approach is to calculate the regression coefficients based on matched samples and then used those 
estimated coefficients to extrapolate over the full range of X’s in the population. 
l Although, if every treatment group individual is matched, the average treatment effect on the treated 
parameter could be recovered.   39
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Table 1: Characteristics of data-generating processes used for 
simulations. 
 
  Descriptives for observed outcomes   
DGP Mean  SD  Skewness  Kurtosis  ATE 
D1  1  1.10 2.00 9.00 1.10 
D2 1  1.60  4.88  52.5  -1.60 
D3 1  0.85  2.10  9.96  -0.85 
D4 1  1.45  9.10  369  -1.45 
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Table 2: Estimated average treatment effect of BCSRT versus MST in 
breast cancer patients. 
 
 
Model: Estimator  ATE (std. error)  Difference from 
ATE(EEE) 
C1: OLS  11,147 (1513)  1,164 (805)
+
C2: log-link GLM  12,318 (1596)   2,335 (635)
++
C3: EEE  9,983 (1350)  - 
    
P1: Quintile-based PS  11,384 (1633)  1,401 (1389) 
P2: OLS-PS  10,869 (1546)   886 (1111) 
P3: IPW-PS  10,994 (2271)  1,011 (2151) 
    
P4a: OLS-DR  10,942 (2649)  959 (2492) 
P4b: log-GLM-DR  11,418 (1981)  1,435 (1752) 
P4c: EEE-DR  10,284 (1788)  301 (1350) 
    
Significant at: ++, 5%, +, 10% 
 






















































































Figure 1: Initial Simulation Results (averaged over 1000 replicates): (a) Distribution of propensity scores by treatment groups; 
(b) Mean X’s by treatment status over estimated propensity score; (c) Std. Deviation of X’s by treatment status over estimated 
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Figure 2: Probability densities of Y under each data generating process, where Y was 



















































-150 -125 -100 -75 -50 -25 0 25 50 75 100 125 150
% Bias




















































-150 -125 -100 -75 -50 -25 0 25 50 75 100 125 150
% Bias




Figure 3: Simulation results on the %Bias and 95% CI in estimating ATE, ratio of Std. 
error of ATE and the ratio of RMSE between alternative estimators and IPW(Saturated 
model) estimator using (a) Data Generating Process D1 and (b) Data Generating Process 
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Figure 4: Simulation results on the %Bias and 95% CI in estimating ATE, ratio of Std. 
error of ATE and the ratio of RMSE between alternative estimators and IPW(Saturated 
model) estimator using (a) Data Generating Process D3 and (b) Data Generating Process 





% optimal:  Data Generating Processes 
  DGP D1  DGP D2  DGP D3  DGP D4 
Optimal Estimator Æ EEE  EEE  OLS-PS Log-GLM-DR 
Methods      
   EEE  43%  81%  7%  12% 
   OLS-PS  39%  0%  89%  0% 
   Log-GLM-DR  7%  0%  0%  46% 
   IPW  11%  19%  4%  42% 
     
 
Figure 5: An algorithm to select optimal estimator (assumes that the initial regression run is the EEE model), w/i = within, nw/i = 
not within; and the percentage of simulated replicate datasets in which a method was found to be optimal following this 
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Figure 6: (a) Distribution of estimated propensity scores by treatment groups; (b) 
Imbalances in mean and standard deviation of Charlson Index score (ChSc) and the 
correlation between CHSc and median Household income between treatment groups at 
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Figure 7: Analysis on cost of breast cancer treatments. Profile of residuals over the 
deciles of linear predictors for (a) OLS, log-GLM and EEE methods and (b) OLS=PS, 
OLS-DR, log-GLM-DR and the EEE-DR methods. 